Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Sales: 2023-2025

Historic Return on Sales for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to -2.17%.

  • bioAffinity Technologies' Return on Sales fell 127.00% to -2.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.17%, marking a year-over-year decrease of 127.00%. This contributed to the annual value of -0.97% for FY2024, which is 217.00% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Return on Sales of -2.17% as of Q3 2025, which was down 42.92% from -1.52% recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Return on Sales high stood at 7.19% for Q1 2023, and its period low was -408.49% during Q2 2023.
  • In the last 3 years, bioAffinity Technologies' Return on Sales had a median value of -1.52% in 2025 and averaged -39.68%.
  • Data for bioAffinity Technologies' Return on Sales shows a peak YoY increase of 40,729bps (in 2024) and a maximum YoY decrease of 888bps (in 2024) over the last 5 years.
  • Over the past 3 years, bioAffinity Technologies' Return on Sales (Quarterly) stood at -3.13% in 2023, then skyrocketed by 217bps to -0.97% in 2024, then crashed by 127bps to -2.17% in 2025.
  • Its Return on Sales stands at -2.17% for Q3 2025, versus -1.52% for Q2 2025 and -1.11% for Q1 2025.